CVS Corp (CVS)
67.50 x 300 68.08 x 100
Post-market by (Cboe BZX)
67.59 +0.39 (+0.58%) 03/27/25 [NYSE]
67.50 x 300 68.08 x 100
Post-market 67.60 +0.01 (+0.01%) 19:35 ET
for Thu, Mar 27th, 2025
Results
download Want to compare other data? Select FieldsSymbol | CVS | ELV | COR | ||
Company | CVS Corp | Elevance Health Inc | Cencora Inc | ||
Price Information | |||||
Exchange | NYSE | NYSE | NYSE | ||
Open | 67.06 | 430.04 | 273.07 | ||
High | 68.07 | 433.73 | 274.93 | ||
Low | 66.81 | 424.78 | 271.17 | ||
Last | 67.59 | 431.95 | 273.97 | ||
Change | +0.39 | +1.42 | +2.58 | ||
% Change | +0.58% | +0.33% | +0.95% | ||
Volume | 6,039,500 | 1,075,200 | 1,015,600 | ||
20-Day Average Volume | 8,592,745 | 1,654,225 | 1,808,530 | ||
Previous Close | 67.20 | 430.53 | 271.39 | ||
Industry | Medical Services | Medical Services | Medical Services | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 66.28 | 417.61 | 261.00 | ||
20-Day Raw Stochastic | 73.72% | 87.23% | 96.37% | ||
20-Day Relative Strength | 62.28% | 60.74% | 70.47% | ||
Weighted Alpha | -3.47 | -14.93 | +19.88 | ||
Today's Opinion | 88% Buy | 8% Buy | 100% Buy | ||
Previous Opinion | 88% Buy | 8% Buy | 100% Buy | ||
Last Month's Opinion | 40% Buy | 56% Sell | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -1.53% since 03/20/25 | -0.54% since 03/20/25 | +2.29% since 03/20/25 | ||
Low | 65.89 on 03/25/25 | 419.53 on 03/25/25 | 265.59 on 03/25/25 | ||
High | 68.69 on 03/21/25 | 436.33 on 03/21/25 | 274.92 on 03/27/25 | ||
1-Month | |||||
%Chg | +4.82% since 02/27/25 | +9.95% since 02/27/25 | +10.02% since 02/27/25 | ||
Low | 64.00 on 03/07/25 | 389.66 on 02/28/25 | 248.59 on 03/06/25 | ||
High | 68.87 on 03/20/25 | 438.14 on 03/18/25 | 274.92 on 03/27/25 | ||
3-Month | |||||
%Chg | +51.92% since 12/27/24 | +16.41% since 12/27/24 | +20.73% since 12/27/24 | ||
Low | 43.65 on 12/30/24 | 364.61 on 01/02/25 | 223.92 on 01/02/25 | ||
High | 68.87 on 03/20/25 | 438.14 on 03/18/25 | 274.92 on 03/27/25 | ||
6-Month | |||||
%Chg | +10.12% since 09/27/24 | -17.56% since 09/27/24 | +21.81% since 09/27/24 | ||
Low | 43.56 on 12/23/24 | 362.21 on 12/19/24 | 218.65 on 10/07/24 | ||
High | 68.87 on 03/20/25 | 524.68 on 10/01/24 | 274.92 on 03/27/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 84,725,424 | 97,881,856 | 52,627,140 | ||
Shares Outstanding, K | 1,260,795 | 227,352 | 193,917 | ||
Annual Sales | 372,809,000,000 | 177,011,000,000 | 293,958,590,000 | ||
Annual Net Income | 4,614,000,000 | 5,980,000,000 | 1,509,120,000 | ||
Last Quarter Sales | 97,710,000,000 | 45,442,000,000 | 81,487,060,000 | ||
Last Quarter Net Income | 1,644,000,000 | 418,000,000 | 488,600,000 | ||
60-Month Beta | 0.54 | 0.86 | 0.51 | ||
Per-Share Information | |||||
Most Recent Earnings | 1.19 on 02/12/25 | 3.84 on 01/23/25 | 3.73 on 02/05/25 | ||
Latest Earnings Date | 05/07/25 | 04/17/25 | 05/07/25 | ||
Most Recent Dividend | 0.665 on 01/23/25 | 1.710 on 03/10/25 | 0.550 on 02/14/25 | ||
Next Ex-Dividends Date | 04/22/25 | 03/10/25 | 02/14/25 | ||
Ratios | |||||
Price/Earnings ttm | 12.27 | 12.84 | 18.89 |